V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30128385 | 30091167 | 1.73 | 86.9 | Disease modification (D) | 2018-10-08 | 2018-10-09 | Cabazitaxel | 02 | N | 111 TRIAL | 101489137 |
| 30170491 | 30091904 | 1.72 | 81 | Disease modification (D) | 2019-05-01 | 2019-05-04 | ECX | 02 | N | 111 TRIAL | 101843288 |
| 30158382 | 30091669 | 1.8 | 97.25 | Curative (C) | 2017-03-01 | 2017-03-03 | GEMCARBO | 02 | N | 111 TRIAL | 101490387 |
| 30154976 | 30091609 | 1.62 | null | null | 2020-01-29 | 2020-01-29 | Cisplatin + Radiotherapy | 02 | N | 111 TRIAL | 100183778 |
| 30154289 | 30091599 | 1.74 | 81.4 | Curative (C) | 2016-11-20 | 2016-11-29 | Carboplatin + Pemetrexed | 02 | N | 111 TRIAL | 100159497 |
| 30133906 | 30091260 | 1.84 | 106 | Palliative (P) | 2017-06-09 | 2017-07-02 | Mitomycin Intravesical | 02 | N | 111 TRIAL | 100106369 |
| 30081173 | 30090154 | 1.73 | 85.7 | Curative (C) | 2019-01-31 | 2019-02-08 | BCG Intravesical | 02 | null | 111 TRIAL | 101745495 |
| 30085837 | 30090264 | 1.77 | 66.25 | null | 2019-08-11 | 2019-09-01 | Cisplatin + Pemetrexed | 02 | N | 111 TRIAL | 101460127 |
| 30093297 | 30090429 | 1.86 | 96 | null | 2015-05-31 | 2015-05-31 | BCG Intravesical | 02 | N | 111 TRIAL | 101335847 |
| 30109785 | 30090782 | 1.73 | 15.9 | Palliative (P) | 2019-02-12 | 2019-03-09 | Ipilimumab | 02 | N | 111 TRIAL | 101764501 |
| 30122098 | 30091040 | 1.78 | 88.8 | Palliative (P) | 2018-06-20 | 2018-06-22 | Capecitabine + Cisplatin | N | N | 111 TRIAL | 100959679 |
| 20039587 | 20086114 | 1.6 | 65 | Palliative (P) | 2019-02-25 | 2019-03-07 | R GCVP | 02 | N | ABC-08 TRIAL | 100986082 |
| 20048665 | 20086396 | 1.69 | 112 | Palliative (P) | 2019-02-05 | 2019-02-19 | REGORAFENIB | 02 | N | ABC-08 TRIAL | 100880269 |
| 20171355 | 20088054 | null | 103 | 03 | 2018-03-07 | 2018-03-07 | Hydroxycarbamide | 02 | N | ABC-08 TRIAL | 100547999 |
| 20204433 | 20088452 | 1.73 | 72.3 | Curative (C) | 2015-08-03 | 2015-08-16 | Paclitaxel albumin (Abraxane) 21day | 02 | N | ABC-08 TRIAL | 100354441 |
| 20036081 | 20085978 | 1.6 | 101 | null | 2018-08-27 | 2018-09-05 | NEO-ESCAPE TRIAL | 02 | null | ABC-08 TRIAL | 101826670 |
| 40049064 | 40122681 | 1.57 | 67.5 | Palliative (P) | 2018-10-12 | 2018-10-12 | EVEROLIMUS | 02 | null | ABEMACICLIB | 100990740 |
| 40046808 | 40122632 | 1.59 | 63 | Palliative (P) | 2019-08-12 | 2019-08-13 | null | 02 | N | ABEMACICLIB | 101110520 |
| 10381938 | 10073071 | 1.6 | 45.1 | null | 2021-10-07 | 2021-10-08 | Paclitaxel albumin (Abraxane) 21day | 02 | null | ABEMACICLIB | 101748891 |
| 10410612 | 10057069 | null | null | null | null | 2019-07-04 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + GEMCITABINE + RITUXIMAB + VINBLASTINE | 02 | null | ABEMACICLIB | 101686065 |
| 10396318 | 10056958 | 1.63 | 80 | Curative (C) | 2019-08-16 | 2019-11-28 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB | 100462041 |
| 10212602 | 10042763 | 0 | 49.4 | 03 | 2019-10-19 | 2019-11-06 | Cabazitaxel | 02 | N | ABEMACICLIB | 100779482 |
| 40058882 | 40122868 | 1.6 | null | null | 2017-04-04 | 2017-04-04 | EVEROLIMUS | N | null | ABEMACICLIB | 101306804 |
| 40167919 | 40125138 | 1.52 | 52.25 | Palliative (P) | 2019-03-09 | 2019-03-11 | DOXORUBICIN | 02 | N | ABEMACICLIB | 100478752 |
| 40046827 | 40122634 | 1.54 | 73 | Curative (C) | 2018-03-08 | 2018-03-20 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL | 02 | N | ABEMACICLIB | 100970007 |
| 10427984 | 10041535 | 1.65 | null | Curative (C) | 2019-07-18 | 2019-07-26 | VINORELBINE | 02 | N | ABEMACICLIB | 100060850 |
| 40051384 | 40122715 | 1.57 | null | Curative (C) | 2016-08-26 | 2016-09-19 | Fulvestrant + Palbociclib | N | N | ABEMACICLIB | 100925341 |
| 40051969 | 40122724 | 1.64 | 99.7 | Curative (C) | 2017-06-28 | 2017-06-30 | null | 2 | N | ABEMACICLIB | 100126562 |
| 40053918 | 40122761 | 1.5 | 53.8 | null | 2019-07-17 | 2019-07-31 | Pertuzumab | 02 | null | ABEMACICLIB | 100201191 |
| 40056449 | 40122810 | 0 | 0 | Neo-adjuvant (N) | 2019-06-04 | 2019-06-06 | Cisplatin + Pemetrexed | 02 | N | ABEMACICLIB | 100022390 |
| 40044632 | 40122593 | null | 75 | Curative (C) | 2018-12-13 | 2018-12-13 | PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | ABEMACICLIB | 100842524 |
| 40060425 | 40122900 | 1.52 | 60 | null | 2019-11-23 | 2019-12-03 | CYCLOPHOSPHAMIDE | 02 | null | ABEMACICLIB | 101083000 |
| 40062822 | 40122958 | 1.78 | 61.4 | Palliative (P) | 2017-09-15 | 2017-09-25 | Abemaciclib | N | N | ABEMACICLIB | 100186080 |
| 40064774 | 40123007 | 1.69 | 66 | Curative (C) | 2018-01-21 | 2018-02-03 | CYCLOPHOSPHAMIDE + DOXORUBICIN + Pertuzumab + Trastuzumab | N | null | ABEMACICLIB | 101400846 |
| 40067086 | 40123059 | 1.66 | 98.7 | Palliative (P) | null | 2017-02-16 | BCG Intravesical | null | N | ABEMACICLIB | 100905640 |
| 40069890 | 40123112 | 1.6 | 73 | null | 2018-02-21 | 2018-03-02 | null | 02 | null | ABEMACICLIB | 100735060 |
| 40071335 | 40123147 | 1.54 | 55.4 | null | 2019-09-26 | 2019-09-26 | Cyclophosphamide+Doce+Tras Main | 02 | null | ABEMACICLIB | 101611394 |
| 40072382 | 40123165 | 1.62 | 119.3 | Palliative (P) | 2019-07-27 | 2019-08-05 | CISPLATIN + RT | 02 | N | ABEMACICLIB | 101475596 |
| 40080775 | 40123327 | 1.52 | 86.8 | null | 2019-08-20 | 2019-08-20 | ARB Trial | null | N | ABEMACICLIB | 100161322 |
| 40100768 | 40123529 | 1.61 | 58.3 | Curative (C) | 2017-10-01 | 2017-10-01 | LANREOTIDE | 02 | N | ABEMACICLIB | 101082744 |
| 40123023 | 40123881 | 1.6 | 97.3 | null | 2019-12-02 | 2019-12-03 | DOCETAXEL + TRASTUZUMAB | 02 | null | ABEMACICLIB | 101763873 |
| 40127614 | 40124001 | 1.52 | 99.5 | null | 2017-08-18 | 2017-12-20 | null | 02 | N | ABEMACICLIB | 100203594 |
| 40132160 | 40124142 | 1.62 | 74.9 | Curative (C) | 2017-01-01 | 2017-01-13 | Cyclophos+Docetaxel+TrastuzumabLoad | 02 | null | ABEMACICLIB | 100087972 |
| 40137958 | 40124320 | 1.54 | 59.6 | null | 2017-07-21 | 2017-07-25 | Trial Unspecified | 02 | N | ABEMACICLIB | 100038185 |
| 40139969 | 40124378 | 1.53 | 91 | Palliative (P) | 2018-12-26 | 2018-12-26 | CARBOPLATIN + ETOPOSIDE | 02 | N | ABEMACICLIB | 100981359 |
| 40155629 | 40124817 | 1.57 | 0 | Curative (C) | 2016-05-23 | 2016-05-31 | null | 02 | Y | ABEMACICLIB | 101803649 |
| 40155937 | 40124827 | 1.69 | 90.95 | null | 2017-04-30 | 2017-04-30 | FLUOROURACIL | 02 | N | ABEMACICLIB | 101166885 |
| 40159061 | 40124911 | 1.6 | 82.5 | Palliative (P) | null | 2016-08-30 | FEC + PACLITAXEL | N | N | ABEMACICLIB | 100182837 |
| 40165743 | 40125084 | 1.53 | null | null | 2017-08-23 | 2017-09-02 | Letrozole + Ribociclib | N | N | ABEMACICLIB | 101683529 |
| 10471336 | 10042382 | 1.63 | 65.4 | Palliative (P) | null | 2019-10-22 | GEMCITABINE + NAB PACLITAXEL | N | N | ABEMACICLIB | 100291093 |